{"id":213116,"name":"DLA PIPER LLP (US) ON BEHALF OF ILLUMINA, INC.","slug":"dla-piper-llp-us-on-behalf-of-illumina-inc","state":"DC","country":"United States of America","description":"Law Firm.","totalSpending":600000,"filings":10,"yearlySpending":[{"year":2021,"income":60000},{"year":2022,"income":360000},{"year":2023,"income":180000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["FEROX STRATEGIES"],"lobbyists":["CRISTINA ANTELO","MARK WILLIAMS","DEBRA DIXON","IVELISSE PORROA-GARCIA"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Legislation and regulations affecting sequencing and array-based solutions for genetic research, clinical and applied markets.","Legislation and regulations affecting sequencing and array-based solutions for genetic research, clinical and applied markets.","Legislation and regulations affecting sequencing and array-based solutions for genetic research, clinical and applied markets.","Legislation and regulations affecting sequencing and array-based solutions for genetic research, clinical and applied markets.","Legislation and regulations affecting sequencing and array-based solutions for genetic research, clinical and applied markets."]}